SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $498,000 | -4.8% | 47,987 | -15.0% | 0.01% | +9.1% |
| Q2 2019 | $523,000 | +110.9% | 56,430 | +108.2% | 0.01% | +120.0% |
| Q1 2019 | $248,000 | -33.2% | 27,109 | -59.3% | 0.01% | -50.0% |
| Q4 2018 | $371,000 | -28.5% | 66,622 | +53.0% | 0.01% | -9.1% |
| Q3 2018 | $519,000 | +8.1% | 43,549 | -7.3% | 0.01% | +22.2% |
| Q2 2018 | $480,000 | – | 46,958 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |